10x Genomics Reaches Analyst Target Price
February 03, 2023 at 07:48 AM EST
In recent trading, shares of 10x Genomics Inc (TXG) have crossed above the average analyst 12-month target price of $49.67, changing hands for $49.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..